EADV 2021

  • Supported by
  • La Roche-Posay

PRESENTATION

The EADV 2021 Congress is an outstanding educational and learning experience for dermatologists and venereologists world-wide. La Roche-Posay continues to push the boundaries of skincare science to improve patients’ quality of life and invites you to discover the content of its interactive booth, hubs and posters presented at EADV 2021, for the latest innovations in dermatology, including advancements in photoprotection and microbiome science.

 
La Roche-Posay presence at EADV


Dr. Delphine Kerob
Paris, France

LA ROCHE-POSAY SYMPOSIUM

Revolution in photoprotection

How to recommend and adapt photoprotection according to skin phototype and dermatoses?
Innovation on UVA: launching a new filter

To know more about photoprotection access JEADV publication

LA ROCHE-POSAY HUBS

MANAGING SKIN SIDE EFFECTS FROM CANCER TREATMENTS: WHERE DO WE STAND?

ATOPIC DERMATITIS: NEW TECHNOLOGY TO ACT FAST DURING FLARE UPS AT ALL AGES

 

POSTERS

[EADV2021-1]
The application of an emollient helps to reduce the cutaneous side effects of anti-cancer treatments
 P. GUYONNET-DEBERSAC, G. LE DANTEC, AL. DEMESSANT-FLAVIGNY

[EADV2021-2]
Prevalence of radiotherapy, chemotherapy and access to supportive Care in cancer in France, Brazil, Russia, the USA & China
 G. BUIRET, V. DELVIGNE, G. LE DANTEC, P. GUYONNET-DEBERSAC, C. TAIEB

[EADV2021-3]
Pain, discomfort, unpleasant sensations: the impact of scars
 JM. AMICI, S. SEITÉ, C. LE FLOC’H, G. LE DANTEC, C. TAIEB

[EADV2021-4]
Prevalence of scars: results of the first international study
 JM. AMICI, S. SEITÉ, C. LE FLOC’H, G. LE DANTEC, C. TAIEB

[EADV2021-5]
Scars and the environment: a first real-life assessment
 JM. AMICI, S. SEITÉ, C. LE FLOC’H, G. LE DANTEC, C. TAIEB

[EADV2021-6]
The use of photoprotection reduces cutaneous side effects of patients undergoing anti-cancer treatments
 P. GUYONNET-DEBERSAC, G. LE DANTEC, AL. DEMESSANT-FLAVIGNY

[EADV2021-7]
AI-ADL: a relevant tool for assessing the burden of adult acne
 B. DRENO, A. KHAMMARI, C. LE FLOC’H, AL. DEMESSANT-FLAVIGNY, J. SHOURICK, C. TAIEB

[EADV2021-8]
Solar exposure in oncology patients: educate and convince
 P. GUYONNET-DEBERSAC, G. LE DANTEC, AL. DEMESSANT-FLAVIGNY

[EADV2021-9]
Sleep disorders in adult acne
 B. HALIOUA, J. SHOURICK, J. TAIEB, C. LE FLOC’H, AL. DEMESSANT-FLAVIGNY, C. TAIEB, B. DRENO

[EADV2021-10]
Evaluation of the biological effect of a high broad spectrum sunscreen with nicotinamide and panthenol repairing photodamaged skin
 G. TELL, N. CALBET, J. MATEU, J. PÉREZ, B. ALEJO, P. IGLESIAS, J. MALVEHY, AL. DEMESSANT-FLAVIGNY, C. LE FLOC’H, L. PRIETO, S. PUIG

[EADV2021-11]
Characterization of photo damaged skin using 3D line-field optical coherence tomography and histopathological correlation
 J. PÉREZ-ANKER, B. ALEJO, P. IGLESIAS, V. BEROT, C. CANO, E. CINOTTI, V. DEL MARMOL, M. FONTAINE, M. MIYAMOTO, J. MONNIER, JL. PERROT, P. RUBEGNI, L. TOGNETTI, M. SUPPRA, AL. DEMESSANT-FLAVIGNY, C. LE FLOC’H, L. PRIETO, J. MALVEHY, S. PUIG

[EADV2021-12]
Management of cutaneous toxicity induced by epidermal growth factor receptor inhibitors (EGFR-I) in squamous cell carcinomas of the head and neck, colorectal or lung cancer
 J. FAYETTE, S. SEITE, A. SARVE, AL. DEMESSANT, C. HERNANDEZ, S. VIZOSO, C. RIGAL, E. BLANC, C. SCHIFFLER

[EADV2021-13]
New clinical evaluation method for lesion count in patients with truncal acne
 L. TOWERSEY, JE. JUNIOR, P. CORREIA, B. SANT’ANNA, C. LE FLOC’H, AL. DEMESSANT-FLAVIGNY

[EADV2021-14]
Algorithm for regenerative dermocosmetic therapy complementary to dermatological procedures for sensitive skin
 A. BRAZ

[EADV2021-15]
Synergistic effects of two dermocosmetics containing different sizes of hayluronic acid in combination with CO2 laser for skin ageing in brazilian women a prospective, controlled study
 A. ROMITI, JE. JUNIOR, P. CORREIA, B. SANT’ANNA, C. LE FLOC’H, AL. DEMESSANT-FLAVIGNY